Emerging Innovations in Viral Vector Production
The current pulse of the industry is defined by a rapid move toward non-viral delivery methods, yet viral vectors remains the gold standard for now. Observing the Cell and Gene Therapy CDMO Market trends, we see a significant push toward stable cell lines for lentiviral production. This innovation aims to replace the inefficient transient transfection methods currently used, which would...
0 Commentaires 0 Parts 715 Vue 0 Aperçu